Toronto Dominion Bank
REVBW icon

Toronto Dominion Bank’s Revelation Biosciences Warrant REVBW Stock Holding History

Toronto Dominion Bank’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$792 Sell
99,050
-500
-0.5% -$5 ﹤0.01% 2204
2026
Q1 		$896 Buy
99,550
+100
+0.1% +$1 ﹤0.01% 2026
2025
Q4 		$796 Hold
99,450
– – ﹤0.01% 1945
2025
Q3 		$1.29K Sell
99,450
-150
-0.2% -$2 ﹤0.01% 1831
2025
Q2 		$1.2K Buy
+99,600
New +$1.21K ﹤0.01% 1711

Other funds holding REVBW

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SIA
Soltis Investment Advisors St. George, Utah $1.8B AUM 27.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Toronto Dominion Bank's REVBW Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Revelation Biosciences Warrant (REVBW) stake by 0.5% in Q2 2026, selling an estimated $5 and leaving 99,050 shares worth $792. The position accounts for ﹤0.01% of the portfolio, ranked #2204.

Toronto Dominion Bank first reported a position in REVBW in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.29K in Q3 2025. 13 funds tracked by Wall St. Rank hold REVBW as of Q2 2026.

  • Toronto Dominion Bank held 99,050 shares of Revelation Biosciences Warrant worth $792 as of Q2 2026.
  • Toronto Dominion Bank sold 500 Revelation Biosciences Warrant shares in Q2 2026, an estimated $5.
  • Revelation Biosciences Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2204 holding.
  • Toronto Dominion Bank first reported a position in Revelation Biosciences Warrant in Q2 2025 and has held it in 5 quarters since.
  • Toronto Dominion Bank's Revelation Biosciences Warrant position peaked at $1.29K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.